Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact.
Saved in:
| Title: | Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact. |
|---|---|
| Authors: | Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Bielo LB; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Adorisio R; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ivanova M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Peruzzo V; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Concardi A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Negrelli M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., D'Ercole M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Porta FM; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Zhan Y; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: nicola.fusco@ieo.it. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Feb 25; Vol. 217, pp. 115233. Date of Electronic Publication: 2025 Jan 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39827722 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Venetis+K%22">Venetis K</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Frascarelli+C%22">Frascarelli C</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bielo+LB%22">Bielo LB</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cursano+G%22">Cursano G</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Adorisio+R%22">Adorisio R</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ivanova+M%22">Ivanova M</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mane+E%22">Mane E</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Peruzzo+V%22">Peruzzo V</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Concardi+A%22">Concardi A</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Negrelli+M%22">Negrelli M</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22D'Ercole+M%22">D'Ercole M</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Porta+FM%22">Porta FM</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zhan+Y%22">Zhan Y</searchLink>; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marra+A%22">Marra A</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Trapani+D%22">Trapani D</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Criscitiello+C%22">Criscitiello C</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Guerini-Rocco+E%22">Guerini-Rocco E</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fusco+N%22">Fusco N</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: nicola.fusco@ieo.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Feb 25; Vol. 217, pp. 115233. <i>Date of Electronic Publication: </i>2025 Jan 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39827722 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2025.115233 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115233 Titles: – TitleFull: Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Venetis K – PersonEntity: Name: NameFull: Frascarelli C – PersonEntity: Name: NameFull: Bielo LB – PersonEntity: Name: NameFull: Cursano G – PersonEntity: Name: NameFull: Adorisio R – PersonEntity: Name: NameFull: Ivanova M – PersonEntity: Name: NameFull: Mane E – PersonEntity: Name: NameFull: Peruzzo V – PersonEntity: Name: NameFull: Concardi A – PersonEntity: Name: NameFull: Negrelli M – PersonEntity: Name: NameFull: D'Ercole M – PersonEntity: Name: NameFull: Porta FM – PersonEntity: Name: NameFull: Zhan Y – PersonEntity: Name: NameFull: Marra A – PersonEntity: Name: NameFull: Trapani D – PersonEntity: Name: NameFull: Criscitiello C – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Guerini-Rocco E – PersonEntity: Name: NameFull: Fusco N IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 02 Text: 2025 Feb 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 217 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |
